An innovative Flu Vaccine For 65+

The flu presents a unique threat for those aged 65+. Age-related decline in immunity, a greater risk of complications, hospitalisations and longer recovery times. To address this problem, Seqirus has created an innovative vaccine, FLUAD Quad, specifically developed to boost the immune response in older people.

Of course, a vaccine is only as good as your ability to get it into people’s arms, so Seqirus called on INSIGHT to ensure 65-plusses knew they could get better protection.

Working in harmony with our general public campaign - FLU FIT - we ensured that those people who needed reassurance to get this new vaccine would not be left wanting.

Targeted assets allowed them to take a deeper dive, with an educational surgery poster and a consumer website, where we translated complex data into bite-sized, easy to digest information that tackled key potential objections.

For HCPs, the story was more detailed and nuanced - we created clinical materials that detailed the efficacy, safety - and the science - of this innovative new vaccine. 

We enhanced the branding of global material with bespoke photography of real Kiwi families, making the benefits of this globally developed solution tangible to New Zealanders.

Consumer channels: Brochures. Posters. Website.

Medical channels: eDetailer. HCP website. Advertising. FLUAD Quad ‘Kit’ for surgeries.